We read every piece of feedback, and take your input very seriously.
To see all available qualifiers, see our documentation.
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
We should add a way to test for content during build / pull requests - especially random cases that I come across in conversations.
For example: Mifamurtide - approved in Europe, not in US
https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297581/ ID: | CHEMBL4297581 Name: | IONIS HTTRX Max Phase: | 3 Phase III Current name is actually Tominersen https://www.ionispharma.com/medicines/ionis-htt/ https://drugs.ncats.io/drug/7QI41X9QWC All of the candidates listed in https://www.ionispharma.com/ionis-innovation/pipeline/ should probably be updated in GSRS and at the drugs site.
The text was updated successfully, but these errors were encountered:
No branches or pull requests
We should add a way to test for content during build / pull requests - especially random cases that I come across in conversations.
For example:
Mifamurtide - approved in Europe, not in US
https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL4297581/
ID: | CHEMBL4297581
Name: | IONIS HTTRX
Max Phase: | 3 Phase III
Current name is actually Tominersen https://www.ionispharma.com/medicines/ionis-htt/
https://drugs.ncats.io/drug/7QI41X9QWC
All of the candidates listed in https://www.ionispharma.com/ionis-innovation/pipeline/ should probably be updated in GSRS and at the drugs site.
The text was updated successfully, but these errors were encountered: